REGISTERED
on 04 Jun 2024
Last Applicant/ Owned by
MELBOURNE VIC 3004
AU
Serial Number
79354136 filed on 08th Sep 2022
Registration Number
7404002 registered on 04th Jun 2024
Correspondent Address
Charles G. Zug
Charles G. Zug Nelson Mullins Riley & Scarborough LLP
Suite 2300, IP Department
Charlotte, NC 28202
UNITED STATES
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
STELLABODY
Immunological antibodies, other than for medical use; reagents for scientific purposes; diagnostic reagents for scientific use; chemical testing reagents for scientific use; laboratory reagents for scientific use; biochemical preparations for laboratory purposes; immunoassay reagents, other than for medical use; enzymes for scientific purposes; chemical diagnostic reagents for scientific use; reco Read More
Classification Information
Class [005]
Pharmaceutical Products
Colostral antibodies for medical purposes; monoclonal antibodies for medical use; monoclonal antibodies for medical diagnostic use; tagged antibodies for medical use; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; monoclonal antibody reagents for medical use; clinical medical reagents for use in the development of monoclonal antibodies; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; immunoassay reagents for medical use; protein arrays for medical use in binding antibodies; protein arrays for medical use in detecting antibodies; biological preparations for pharmaceutical purposes for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions; immunological products, namely, pharmaceutical preparations for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions; pharmaceutical immunoglobulin preparations for treatment of immunological disorders; vaccines; vaccine adjuvants; pharmaceutical products for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Immunological antibodies, other than for medical use; reagents for scientific purposes; diagnostic reagents for scientific use; chemical testing reagents for scientific use; laboratory reagents for scientific use; biochemical preparations for laboratory purposes; immunoassay reagents, other than for medical use; enzymes for scientific purposes; chemical diagnostic reagents for scientific use; recombinant protein being biochemical preparations for scientific use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79354136
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 047911.09001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Nov 2024 | GENERIC MADRID TRANSACTION CREATED |
| 16th Nov 2024 | GENERIC MADRID TRANSACTION SENT TO IB |
| 04th Sep 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 04th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 04th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
| 22nd Apr 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 03rd Apr 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 03rd Apr 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 19th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Mar 2024 | PUBLISHED FOR OPPOSITION |